Cumberland Pharmaceuticals CPIX Change in unpaid invoices for intangible asset additions
Change in unpaid invoices for intangible asset additions at other companies
Other financials
Where this comes from
Reported directly by Cumberland Pharmaceuticals in its filing.
Tagged under the XBRL concept cpix:PurchasesOfIntangibleAssetsIncurredButNotYetPaid.
The official record: Cumberland Pharmaceuticals’s 10-K, filed March 9, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cumberland Pharmaceuticals's change in unpaid invoices for intangible asset additions.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cumberland Pharmaceuticals's change in unpaid invoices for intangible asset additions?
- Cumberland Pharmaceuticals (CPIX) reported change in unpaid invoices for intangible asset additions of $1.18K in Q4 2025.
- How has Cumberland Pharmaceuticals's change in unpaid invoices for intangible asset additions changed year-over-year?
- Cumberland Pharmaceuticals's change in unpaid invoices for intangible asset additions increased by 791.9% year-over-year, from $132.5 to $1.18K.
- What is the long-term trend for Cumberland Pharmaceuticals's change in unpaid invoices for intangible asset additions?
- Over 4 years (2021 to 2025), Cumberland Pharmaceuticals's change in unpaid invoices for intangible asset additions has grown at a -42.6% compound annual growth rate (CAGR), from -$43.47K to $4.73K.
- What does change in unpaid invoices for intangible asset additions mean?
- Captures the change in accounts payable or accrued liabilities specifically related to the acquisition of intangible assets such as patents, licenses, or product rights. This metric highlights the difference between the accounting recognition of asset additions and the actual cash outflow. It is used to reconcile capital expenditure commitments with cash flow timing.